John Inglis graduated from Edinburgh University Medical School with a Ph.D. in immunology and soon afterwards joined the editorial staff of the weekly medical journal The Lancet. Three years later, he founded the monthly review journal, Immunology Today (now Trends in Immunology) and edited it for seven years while launching and managing other journals. Inglis has authored articles on biomedicine for British newspapers and New Scientist magazine.
In 1987, he came to the United States to found Cold Spring Harbor Laboratory Press, building on a respected publishing program that consisted then of the Cold Spring Harbor Symposium proceedings, a small number of monographs and manuals, and the 6-month-old journal Genes & Development. Today, the Press is a digital publisher of 9 journals, 200 books in print and electronic formats, and online media with varied business models. It has developed two of the world’s top genetics journals as well as many laboratory manuals, handbooks, and monographs that scientists worldwide regard as essential. The mission of the Press is to create publications and services that help scientists succeed, while contributing funds to the Laboratory and maintaining its exceptional reputation in scientific communication and education.
Inglish also co-founded and manages bioRxiv, a service of the Laboratory launched in 2013 that has become the largest source of preprints of research papers in the life sciences.
